Prostate Cancer Screening: An Update on New Approaches
Distinguishing life-threatening from indolent tumors has not been possible thus far, but this could change with the debut of better tests.
Diagnosis & Disease Information
BP Guidelines May be Inappropriate for HD Patients
SEATTLE—Guidelines recommend that hemodialysis (HD) patients have predialysis BP levels below 140/90 mm Hg, but study findings suggest that such levels may increase their risk of death, according to David Goodkin, MD, an investigator with Arbor Research Collaborative for Health.
Boston Scientific, Bladder Health Network Enter Pact
Boston Scientific Corp., of Natick, Mass., has entered into a four-year exclusive marketing agreement with Bladder Health Network (BHN), a privately held company headquartered in Jackson, Miss., that offers advanced testing solutions for urinary incontinence.
New Formulation of PAH Medication Is Now Available
Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, is now commercially available, according to the drug’s maker, Actelion Pharmaceuticals US, Inc., of South San Francisco, Calif.
Data Support PCa Vaccine’s Mechanism of Action
Phase 3 trial data presented at the American Association of Cancer Research annual meeting support the mechanism of action of Provenge (sipuleucel-T), a novel investigative immunotherapy for advanced prostate cancer, according to a statement issued by Dendreon Corp., of Seattle, which is developing the treatment.
Buccal Tablets for Oropharyngeal Candidiasis Cleared
The FDA has approved Oravig (miconazole) buccal tablets for the treatment of oropharyngeal candidiasis in adults and childen aged 16 years and older.
High-Resolution Camera for Medical Imaging Approved
Toronto-based hybridyne Imaging Technologies has received FDA clearance for ProxiScan, a high-resolution gamma camera for detecting cancer and other abnormalities.
Peritoneal Dialysis Called Underused
Reasons include a lack of nephrologist training in the modality and a number of mistaken beliefs.
Focal Ablation May Treat PCa Relapses
TAMPA, Fla.—Magnetic resonance (MR)-guided ablative therapy using laser thermal energy or cryoablation could provide another option for treating locally recurrent prostate cancer after radical retropubic prostatectomy (RRP), results from a pilot study suggest.
Drug Improved Metastatic Bladder Cancer Survival
In a recent study, zoledronic acid decreased the incidence of skeletal-related events (SREs) and improved one-year survival in patients with bone metastases from bladder cancer, according to a study.
- Loading...
Loading...
Next post in Bladder Cancer
Loading... 
Loading...